logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Eye Tech Care’s Ultrasound Glaucoma Treatment Approved for China Use

Nov 1, 2017

Life Science

Grail courts new backers, loses 2 top executives: reports

Nov 1, 2017

Life Science

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Announces Fifth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone

Nov 1, 2017

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Receives Provisional U.S. Patent for a Hemp Protein Isolate – Video Hosted on InvestmentPitch.com

Nov 1, 2017

Life Science

Lexaria Bioscience CSE:LXX Biotechnology, Cannabis, 生物科技,大麻

Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECHTM Delivery of THC, NSAIDs, Nicotine and Vitamins

Oct 31, 2017

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Receives Provisional Patent for Hemp Protein Isolate From U.S. Patent Office

Oct 31, 2017

Life Science

DelMar Pharmaceuticals Inc NASDAQ:DMPI

DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Component of Combination Chemotherapy Regimens for the Treatment of Solid Tumors including Brain and Ovarian Cancer

Oct 31, 2017

Life Science

Xynomic In-Licenses RAF Inhibitor from Boehringer in $502 Million Deal

Oct 31, 2017

Life Science

Novartis announces $3.9bn deal for French drugmaker

Oct 30, 2017

Life Science

Lexaria Bioscience CSE:LXX Biotechnology, Cannabis, 生物科技,大麻

Lexaria Announces Public Webinar November 1

Oct 27, 2017

Life Science

NAI500 Investment Destination Series Part 1 - learn about investment in Vancouver - China investment - Chinese investors

NAI500 Investment Destination Series – Learn about Investment in Vancouver Part 1

Oct 26, 2017

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

DelMar Pharmaceuticals Inc NASDAQ:DMPI

ONCLIVE: Novel Alkylating Agent Defies Mechanisms of Resistance in GBM Tumors

Oct 25, 2017

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

Maple Leaf Green World Inc TSXV:MGW Agriculture, Biotechnology, Consumer Products and Services, Cannabis, 农业,生物科技,消费品,大麻

Maple Leaf Submits Building Permit Application for its Telkwa, B.C. Facility and Enters into an Intent to Lease with Woodmere Nursery Ltd.

Oct 24, 2017

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid’s Prosnack Natural Foods Inc. Opens National Account

Oct 24, 2017

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Announces Right of First Refusal Agreement with Hepalink USA Inc.

Oct 24, 2017

Energy, Financial Service, Life Science, Mining, Others, Precious Metals, Real Estate, Technology

GIMDx/Improve Medical Gain China Rights to PD-L1 Quantifying Assay

Oct 19, 2017

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Aquires Prosnack Natural Foods Inc. and Closes Final Tranche for $333,835

Oct 19, 2017

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Successfully Closes Financing

Oct 19, 2017

Life Science

  • ‹‹ Previous
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada